Unknown

Dataset Information

0

Myocardial T1 Measurement Predicts Beneficial LV Remodeling After Long-Term Heart Failure Therapy.


ABSTRACT: The myocardial longitudinal relaxation time (T1) on cardiac magnetic resonance imaging (CMR) can quantify myocardial fibrosis in the presence or absence of visually detectable late gadolinium (Gd) enhancement (LGE). Mineralocorticoid receptor antagonist (MRA) treatment produces beneficial remodeling in nonischemic dilated cardiomyopathy (NIDCM). We assessed the hypothesis that interstitial myocardial fibrosis measured with the use of CMR predicts left ventricular (LV) beneficial remodeling in NIDCM after heart failure (HF) treatment including MRAs.Twelve patients with NIDCM, on stable beta-blocker and angiotensin-converting enzyme inhibitor/angiotensin receptor-blocking therapy, were studied before and after 6-29 months of treatment with MRAs, by means of CMR assessment of LV structure, function, and T1 from standard Look-Locker sequences (T1LL). All patients had depressed cardiac function, dilated left ventricles, and no visual LGE. After adding MRA to HF treatment, the LV ejection fraction increased and the LV end-systolic volume index (LV end-systolic volume/m2) decreased in all patients (P?

SUBMITTER: Bradham WS 

PROVIDER: S-EPMC5350022 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Myocardial T1 Measurement Predicts Beneficial LV Remodeling After Long-Term Heart Failure Therapy.

Bradham William S WS   Bell Susan P SP   Adkisson Douglas W DW   Smith Holly M HM   Harrell Frank E FE   Lawson Mark A MA   Ooi Henry H   Sawyer Douglas B DB   Kronenberg Marvin W MW  

Journal of cardiac failure 20161208 3


<h4>Background</h4>The myocardial longitudinal relaxation time (T1) on cardiac magnetic resonance imaging (CMR) can quantify myocardial fibrosis in the presence or absence of visually detectable late gadolinium (Gd) enhancement (LGE). Mineralocorticoid receptor antagonist (MRA) treatment produces beneficial remodeling in nonischemic dilated cardiomyopathy (NIDCM). We assessed the hypothesis that interstitial myocardial fibrosis measured with the use of CMR predicts left ventricular (LV) benefici  ...[more]

Similar Datasets

| S-EPMC5256135 | biostudies-literature
| S-EPMC6233646 | biostudies-literature
| S-EPMC4483994 | biostudies-literature
| S-EPMC5341031 | biostudies-literature
| S-EPMC8177638 | biostudies-literature
| S-EPMC4633018 | biostudies-literature
| S-EPMC6765153 | biostudies-literature
| S-EPMC10978413 | biostudies-literature
| S-EPMC6434939 | biostudies-literature
| S-EPMC4142642 | biostudies-literature